Catherine Regni serves as the Director of Quality Assurance at C2N Diagnostics since June 2023, following a decade-long tenure at MilliporeSigma where the roles included Quality Engineering Supervisor, Principal Scientist, and Validation Engineer. With expertise in project management, risk assessment, and regulatory compliance, Catherine has led initiatives ensuring large-scale biologics manufacturing is executed within budget and specifications. Previous positions at Sigma-Aldrich and St. Jude Children's Research Hospital contributed to a strong foundation in analytical instrument validation, quality enhancement of enzyme and protein products, and development of recombinant protein products. Catherine holds a Ph.D. in Biochemistry from the University of Missouri-Columbia and a Business Analytics Certificate from Webster University.
This person is not in any teams
This person is not in any offices